Powering no-cost athlete payment wallets and debit cards on Datavault AI’s planned NIL Exchange, with embedded banking across the Information Data Exchange® MILWAUKEE, July 21, 2026 (GLOBE NEWSWIRE) — Fiserv, Inc. (NASDAQ: FISV), a global leader in payments and financial technology, today announced it will serve as the exclusive embedded financial services and payments provider for Datavault AI, Inc. (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset tokenization technologies. Fiserv will embed banking, payments, and card programs directly into Datavault AI-powered marketplaces and exchanges. Through its Embedded Finance platform, Fiserv will enable banking, payments, and digital asset programs for Datavault AI and its customers. The relationship will allow Datavault AI to activate...

LONDON, July 21, 2026 (GLOBE NEWSWIRE) — Apollo, a Skyward Group company (Nasdaq: SKWD), the innovation inspired insurance platform, announces the appointment of David Burke as class lead to its product recall line, highlighting Apollo’s continued investment in underwriting talent and specialist expertise. Burke will lead the underwriting strategy for Apollo’s product recall offering, driving continued expansion of the business while broadening beyond its market leading automotive recall capabilities into additional profitable recall sectors. He joins Apollo from Hiscox, where he spent the past 10 years leading the product recall unit, becoming a partner in 2021. The addition of Burke to the Apollo team builds on Apollo’s established strength in the recall market. Apollo recently ranked second in Gracechurch’s ‘2026 London’s Leading...

New External Manager Brings Together SuRo Capital’s 15-Year Private Investment Track Record and Magnetar’s Institutional Capabilities as an $18 Billion Investment Manager Formerly SuRo Capital Corp., Neostellar Capital Corp. Is Now Trading on Nasdaq Under New Ticker “NSLR” NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) — Neostellar Capital Corp. (“Neostellar”, the “Company”, “we”, “us”, and “our”) (Nasdaq: NSLR) formerly SuRo Capital Corp., today announced its launch as a newly rebranded, publicly traded investment platform designed to expand access to high-growth, venture-backed private companies through its transition to an externally managed structure. The new structure enhances the Company’s ability to create long-term shareholder value through a new joint venture investment...

VigiLynx delivers first-of-its-kind VeeaCloud™-managed systems of intelligence combining Veea SecureConnect™, AIoT, and VeeaVision™ video surveillance with Edge AI MEXICO CITY, July 21, 2026 (GLOBE NEWSWIRE) — Veea Inc. (“Veea”) (NASDAQ: VEEA), a pioneer in AI-powered cybersecure distributed intelligence on hyperconverged heterogeneous edge-native infrastructure, today announced the commercial availability of VigiLynx™. Available through Veea’s distributors and channel partners globally, VigiLynx introduces a new category of edge intelligence and automation for business locations. For a limited time, in Mexico, eligible new and existing Telcel Internet Gestionado customers can receive VigiLynx as a free service for the duration of their contract by downloading the AIoT and VeeaVision apps in SecureConnect...

Company CEO has been a featured presenter at several recent industry events on the emergence of endovascular robotics as expert speaking opportunities raising profile of the Company throughout medtech market HINGHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, will be participating at this year’s Society of Robotic Surgery (SRS) annual meeting, being held from July 23-26, in Fort Lauderdale, FL. Last year’s meeting was the first time that endovascular robotics was featured at SRS, and with the Company’s FDA clearance less than a year ago and the growing adoption of the LIBERTY System at leading academic centers in the U.S. for a broad range of peripheral endovascular procedures, the Company believes the continued focus...

A Promising Strategy for Improving Production for Applications in Biotechnology Research MELBOURNE, Australia, July 21, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced that the Company and its joint research partners at the Universities of Jaén and Granada published key findings in a peer reviewed journal, Microbial Cell Factories, regarding the evaluation of recombinant trypsinogen and chymotrypsinogen for improving production for applications in biotechnology research. Specifically, human therapeutic use intended for the treatment of a range of chronic diseases including cancer and fibrosis. The Microbial Cell Factories journal is a leading...

– Podium presentation at the American Head and Neck Society (AHNS) 12th International Conference on Head and Neck Cancer to report results from a study of Alpha DaRT® in combination with pembrolizumab (Keytruda®) in elderly patients with locally advanced or metastatic head and neck squamous cell carcinoma (HNSCC) – – Among all nine evaluable patients, the combination produced a systemic objective response rate (ORR) of 100%, including four complete responses and five partial responses, compared to just 19% ORR from historical benchmarks for pembrolizumab monotherapy in this setting – – Median overall survival of 18.2 months and median progression-free survival of 5.4 months compare favorably with historical benchmarks for pembrolizumab monotherapy in this setting of 12.3 months and 3.2 months, respectively...

Jilin, China, July 21, 2026 (GLOBE NEWSWIRE) — Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today issued the following statement in response to recent unusual trading activity in the price and trading volume of its Class A ordinary shares. The Company does not normally comment on market activity or rumors. However, in light of the magnitude of the recent trading activity in the Company’s securities, the Company is providing the following statement. The Company confirms that it is not aware of any material non-public information regarding the Company, its business, financial condition, or operations that would account for...

Company to Meet with Prospective Customers and Partners at Europe’s Premier Energy Trading Gathering, Expected to Draw More Than 2,500 Market Participants TEL AVIV, Israel, July 21, 2026 (GLOBE NEWSWIRE) — PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced that its DeepSolar business unit will participate in Energy Trading Week Europe 2026, taking place September 24–25, 2026, at the Business Design Centre in London. The participation follows several recent platform milestones, including DeepSolar’s participation in the NVIDIA Connect program, as PRF continues to advance GridFeed™, its AI-driven platform for renewable energy trading, market participation and revenue optimization, built on its DeepSolar Predict™ AI engine. According to the event organizers, the conference is expected to bring...

Avis Files Settlement Agreement Related to Short Swing Profits Litigation PARSIPPANY, N.J. and NAPLES, Fla., July 21, 2026 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) (“Avis” or the “Company”) and Pentwater Capital Management LP (“Pentwater” and collectively with Avis, the “Parties”) today announced Avis has filed a motion in the United States District Court for the Southern District of New York, in case no. 1:26-cv-05512-CM, seeking approval of a settlement agreement (the “Settlement”) reached between the Parties. Avis appreciates Pentwater’s willingness to resolve the Section 16(b) Litigation without the need for further proceedings. As previously disclosed, the Settlement resolves litigation Avis filed on June 16, 2026, against Pentwater and certain affiliated persons, seeking recovery of short swing profits under...